Sclerostin antibody treatment improves bone mass, bone strength, and bone defect regeneration in rats with type 2 diabetes mellitus
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sclerostin antibody treatment improves bone mass, bone strength, and bone defect regeneration in rats with type 2 diabetes mellitus
Authors
Keywords
-
Journal
JOURNAL OF BONE AND MINERAL RESEARCH
Volume 28, Issue 3, Pages 627-638
Publisher
Wiley
Online
2012-10-30
DOI
10.1002/jbmr.1803
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Complications of Ankle Fracture in Patients With Diabetes
- (2016) Saad B. Chaudhary et al. JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS
- Circulating Sclerostin Levels and Bone Turnover in Type 1 and Type 2 Diabetes
- (2012) Luigi Gennari et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Bone, sweet bone—osteoporotic fractures in diabetes mellitus
- (2012) Christine Hamann et al. Nature Reviews Endocrinology
- Fracture healing under healthy and inflammatory conditions
- (2012) Lutz Claes et al. Nature Reviews Rheumatology
- Delayed bone regeneration and low bone mass in a rat model of insulin-resistant type 2 diabetes mellitus is due to impaired osteoblast function
- (2011) Christine Hamann et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Sclerostin antibody treatment enhances bone strength but does not prevent growth retardation in young mice treated with dexamethasone
- (2011) M. Marenzana et al. ARTHRITIS AND RHEUMATISM
- Diabetes and bone health: the relationship between diabetes and osteoporosis-associated fractures
- (2011) Salila Kurra et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Increased Bone Formation and Bone Mass Induced by Sclerostin Antibody Is Not Affected by Pretreatment or Cotreatment with Alendronate in Osteopenic, Ovariectomized Rats
- (2011) Xiaodong Li et al. ENDOCRINOLOGY
- Circulating Levels of Sclerostin Are Increased in Patients with Type 2 Diabetes Mellitus
- (2011) Antonia García-Martín et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Treatment with a sclerostin antibody increases cancellous bone formation and bone mass regardless of marrow composition in adult female rats
- (2010) XiaoYan Tian et al. BONE
- Malfunction of bone marrow-derived osteoclasts and the delay of bone fracture healing in diabetic mice
- (2010) Toshiyuki Kasahara et al. BONE
- The effect of diabetes mellitus on osseous healing
- (2010) M. Retzepi et al. CLINICAL ORAL IMPLANTS RESEARCH
- Type 2 diabetes mellitus impairs bone healing of dental implants in GK rats
- (2010) Feng Wang et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee
- (2010) A. Michael Parfitt et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Sclerostin antibody treatment enhances metaphyseal bone healing in rats
- (2010) Fredrik Agholme et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength
- (2010) Michael S Ominsky et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Inhibition of sclerostin by monoclonal antibody increases bone formation, bone mass, and bone strength in aged male rats
- (2010) Xiaodong Li et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody
- (2010) Desmond Padhi et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Guidelines for assessment of bone microstructure in rodents using micro-computed tomography
- (2010) Mary L Bouxsein et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Inhibition of sclerostin by monoclonal antibody enhances bone healing and improves bone density and strength of nonfractured bones
- (2010) Michael S Ominsky et al. JOURNAL OF BONE AND MINERAL RESEARCH
- High-Resolution Peripheral Quantitative Computed Tomographic Imaging of Cortical and Trabecular Bone Microarchitecture in Patients with Type 2 Diabetes Mellitus
- (2010) Andrew J. Burghardt et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Skeletal changes associated with the onset of type 2 diabetes in the ZDF and ZDSD rodent models
- (2009) Susan Reinwald et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- A Short Treatment With an Antibody to Sclerostin Can Inhibit Bone Loss in an Ongoing Model of Colitis*
- (2009) Alison Eddleston et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Bone mass and strength in older men with type 2 diabetes: The Osteoporotic Fractures in Men Study
- (2009) Moira A Petit et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Diabetes and Its Complications and Their Relationship with Risk of Fractures in Type 1 and 2 Diabetes
- (2008) Peter Vestergaard et al. CALCIFIED TISSUE INTERNATIONAL
- Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength in a Rat Model of Postmenopausal Osteoporosis*
- (2008) Xiaodong Li et al. JOURNAL OF BONE AND MINERAL RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now